![International Myeloma Foundation (IMF) Launches 31 Days of Resilience Campaign for Myeloma Action Month in March 2021 International Myeloma Foundation (IMF) Launches 31 Days of Resilience Campaign for Myeloma Action Month in March 2021](https://imf-d8-prod.s3.us-west-1.wasabisys.com/2021-02/31-days-resilience-myeloma-action-month.png)
International Myeloma Foundation (IMF) Launches 31 Days of Resilience Campaign for Myeloma Action Month in March 2021
![International Myeloma Foundation (IMF) Launches M-Power New York to Improve Multiple Myeloma Outcomes in the Black Community International Myeloma Foundation (IMF) Launches M-Power New York to Improve Multiple Myeloma Outcomes in the Black Community](https://mma.prnewswire.com/media/1898915/m_power_new_york.jpg?p=facebook)
International Myeloma Foundation (IMF) Launches M-Power New York to Improve Multiple Myeloma Outcomes in the Black Community
![The International Myeloma Foundation (IMF) Honors 2022 Research Achievement Awardees, Dr. Hervé Avet-Loiseau and Dr. Bruno Paiva The International Myeloma Foundation (IMF) Honors 2022 Research Achievement Awardees, Dr. Hervé Avet-Loiseau and Dr. Bruno Paiva](https://mma.prnewswire.com/media/1834854/International_Myeloma_Working_Group_IMWG_Logo.jpg?p=facebook)
The International Myeloma Foundation (IMF) Honors 2022 Research Achievement Awardees, Dr. Hervé Avet-Loiseau and Dr. Bruno Paiva
![Isatuximab, Carfilzomib, Lenalidomide, and Dex (Isa-KRd) in Pts with High-Risk Newly Diagnosed MM - YouTube Isatuximab, Carfilzomib, Lenalidomide, and Dex (Isa-KRd) in Pts with High-Risk Newly Diagnosed MM - YouTube](https://i.ytimg.com/vi/PXivu68N3ck/maxresdefault.jpg)